AB-10-RE65_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, 3-Hydroxy-4-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]benzonitrile, splicing modulator targeting RNU1-4, SNRPC, RNU1-3, RNU1-2, RNU1-1 (Novartis, 136253042)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/136253042
Similar Terms
Downloads & Tools

Genes

14 genes differentially expressed following the AB-10-RE65_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
VAPA VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa 0.821194
RPL41 ribosomal protein L41 0.568693
KRT81 keratin 81, type II 0.297769
APRT adenine phosphoribosyltransferase 0.296844
JPT1 Jupiter microtubule associated homolog 1 0.281968
MYL2 myosin, light chain 2, regulatory, cardiac, slow 0.251804
TAGLN transgelin 0.226605
UQCC3 ubiquinol-cytochrome c reductase complex assembly factor 3 0.200046

decreased expression

Symbol Name Standardized Value
NME1-NME2 NME1-NME2 readthrough -0.297769
FAM3A family with sequence similarity 3, member A -0.226605
ST3GAL2 ST3 beta-galactoside alpha-2,3-sialyltransferase 2 -0.218811
DHRS2 dehydrogenase/reductase (SDR family) member 2 -0.217493
ELAVL1 ELAV like RNA binding protein 1 -0.217493
ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein -0.217493